NCT00400361View on ClinicalTrials.gov

A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

April 30, 2011

Study Completion Date

April 30, 2011

Conditions
Neoplasms
Interventions
DRUG

RG1507

Administered iv, either weekly or 3 weekly, at escalating doses (with a starting dose of 1mg/kg) (7 cohorts).

Trial Locations (3)

77030

Houston

80045

Aurora

08901

New Brunswick

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00400361 - A Multiple Ascending Dose Study of R1507 in Patients With Advanced Solid Tumors. | Biotech Hunter | Biotech Hunter